OTC : ORXOF

Orexo AB (publ)

$1.55 USD

$0 (0.0%)

Volume
2K
Average Volume
127
Market Capitalization
$54.45M
P/E Ratio
-1.64
Dividend Yield
0.00%
Price Target
Year High
$3.23
Year Low
$1.55
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.65
Company Overview

OTC

Nikolaj Sorensen

Drug Manufacturers - Specialty & Generic

Healthcare

ORXOF

65

SE

USD

https://www.orexo.com

46 1 87 80 88 00

N/A

N/A

Liquidity Metrics

0.04

1.65

1.65

1.20

0.00

Sales & Valuation

$25.93M

3.89

1.87

40.96

0.35

Profitability

-$3.74

-$129.47M

-236.32%

-271.80%

-136.72%

-59.93%

P/E Metrics

-1.64

0.02

0.02

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

-0.06

5/9

$149.9M

$514.6M

$243.3M

-$302M

Key Metrics (TTM)

$252.87M

1.94

-1.01

1.65

-136.72%

-106.85%

-59.32%

2.39%

-1409 days

Company Executives
Name Title
Fredrik Jarrsten Executive Vice President & Chief Financial Officer
Nikolaj Sorensen President & Chief Executive Officer
Robert Ronn Senior Vice President and Head of R&D
Cecilia Coupland Senior Vice President & Head of Operations
Lisa Moore Senior Vice President of Products & Portfolio Strategy
Raheleh Nassaji Senior Vice President of Business Development
Edward Kim Senior VP & Chief Medical Officer
Lena Wange Investor Relations & Communications Director
Poll Results

No votes yet today — be the first to share your view!

About Orexo AB (publ) (OTC:ORXOF) Stock

Orexo AB (publ) functions as a specialized pharmaceutical company, focusing on the innovation, advancement, and marketing of both conventional medicines and digital therapeutic solutions. Its commercial reach extends across the United States, Europe, and the United Kingdom. The firm's existing line of pharmaceutical products includes Zubsolv tablets, which are prescribed for addressing opioid dependence; Abstral, used to manage acute breakthrough pain in cancer patients; and Edluar, formulated for the brief treatment of insomnia. Looking to its future offerings, Orexo is actively progressing several developmental candidates: OX124, an emergency medication for naloxone rescue; OX125, an intervention for nalmefene rescue; OX640, a potential treatment for allergic reactions; and OX338, a subl ... ingual ketorolac tablet designed for moderate to severe pain relief. Furthermore, the company is engaged in the OX-MPI program, which aims to tackle microvascular diseases often linked with chronic inflammatory conditions. Beyond traditional drugs, Orexo provides a selection of digital health therapies, such as deprexis, a program tailored for treating mild to severe depression; vorvida, targeted at alcohol use disorder; and modia, a digital tool for managing opioid use disorder. Established in 1994, Orexo AB (publ) operates from its primary corporate offices located in Uppsala, Sweden.

Frequently Asked Questions

What is the current Orexo AB (publ) (ORXOF) stock price?

Orexo AB (publ)(OTC:ORXOF) stock price is $1.55 in the last trading session. During the trading session, ORXOF stock reached the peak price of $3.23 while $1.55 was the lowest point it dropped to. The percentage change in ORXOF stock occurred in the recent session was 0.0% while the dollar amount for the price change in ORXOF stock was $0.

ORXOF's industry and sector of operation?

The OTC listed ORXOF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of ORXOF?

Fredrik Jarrsten | Executive Vice President & Chief Financial Officer
Nikolaj Sorensen | President & Chief Executive Officer
Robert Ronn | Senior Vice President and Head of R&D
Cecilia Coupland | Senior Vice President & Head of Operations
Lisa Moore | Senior Vice President of Products & Portfolio Strategy

How many employees does ORXOF have?

Number of ORXOF employees currently stands at 65. ORXOF operates from P.O. Box 303, Uppsala, UP 751 05, SE.

Link for ORXOF official website?

Official Website of ORXOF is: https://www.orexo.com

How do I contact ORXOF?

ORXOF could be contacted at phone #46 1 87 80 88 00 and can also be accessed through its website. ORXOF operates from P.O. Box 303, Uppsala, UP 751 05, SE.

How many shares of ORXOF are traded daily?

The average number of ORXOF shares traded daily for last 3 months was 127.

What is the market cap of ORXOF currently?

The market value of ORXOF currently stands at $54.45M with its latest stock price at $1.55